|
5-FU Clinical Trials
18 actively recruiting trials across 5 locations
▲ +3 trials since August 2026
Also known as: 5 Fluorouracil, Adrucil, Fluorouracil, fluorouracil
Pipeline
Phase 1: 3Phase 2: 8Phase 3: 3Phase 1/2: 3
Top Sponsors
- Fudan University2
- Astellas Pharma Global Development, Inc.2
- Zhejiang Doer Biologics Co., Ltd.1
- West China Hospital1
- UNC Lineberger Comprehensive Cancer Center1
Indications
- Cancer18
- Colorectal Cancer3
- Gastroesophageal Carcinoma1
- Diffuse Pleural Mesothelioma1
- Sub-study 5 Unresectable Pleural Mesothelioma (Volrustomig Monotherapy)1
Other12 trials
Phase 2
Phase 2
N/A
Los Angeles, California2 trials
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
START Los Angeles, LLC
Phase 1/2
Boston, Massachusetts1 trial
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
Massachusetts General Hospital
Phase 1
Saint Louis Park, Minnesota1 trial
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Metro Minnesota Community Oncology Research Consortium
Phase 3
Basking Ridge, New Jersey1 trial
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Phase 1
Chapel Hill, North Carolina1 trial
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.